Market Cap 757.33M
Revenue (ttm) 138.10M
Net Income (ttm) 31.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 23.08%
Debt to Equity Ratio 0.00
Volume 8,905,500
Avg Vol 7,026,716
Day's Range N/A - N/A
Shares Out 170.19M
Stochastic %K 2%
Beta 2.44
Analysts Strong Sell
Price Target $13.22

Company Profile

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index f...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 515 3185
Fax: 650 351 0353
Address:
151 Oyster Point Boulevard, Suite 400, South San Francisco, United States
Bar_ryFlo
Bar_ryFlo Mar. 21 at 7:36 PM
$CTMX biotech under the radar and a tight coil here could expand fast with volume
1 · Reply
PleadNoContest
PleadNoContest Mar. 21 at 2:42 PM
$CTMX https://fintel.io/seps/us/ctmx This is one shtty earnings report. No FDA approved Varsetta until next year. Just a swarm of delusional pumpers.
1 · Reply
Terebc
Terebc Mar. 20 at 11:51 PM
$CTMX well too bad I didn’t wait, I bought 21,000 shares at 4.58 But I know this will go to 5.50 or more in a week or so
1 · Reply
PleadNoContest
PleadNoContest Mar. 20 at 9:35 PM
0 · Reply
Turdsniffer
Turdsniffer Mar. 20 at 7:44 PM
$CTMX pathetic
0 · Reply
LabPsycho
LabPsycho Mar. 20 at 6:05 PM
$CTMX @toandph Well, IMO, many of these biotechs are up 100-1200% in 11 months, and many have diluted huge along the way up,sucked many $ billions of dollars out of the now dried up biotech pool, so evern 60% retrace leaves many up substantially. I think the great unwinding started a few weeks ago. CTMX popped on early stage clinical results - the huge dilution with insider selling is rarely a good omen. I see this easily retracing below $4. Good luck.
2 · Reply
LabPsycho
LabPsycho Mar. 20 at 4:54 PM
$CTMX My calculations suggesting this is going below $4.25 soon
2 · Reply
biolover
biolover Mar. 20 at 4:32 PM
$MGNX With this fierce repetition from China on all classes of therapeutics. It is enticing to be FIC with descent time lead. That what I like about $MGNX adam9 ADC. Also GI expression ( in these cancers with limited ADC targets .. seen $CTMX trying to mask .. ) , no reported ILD and responses within one year of phase 1 start ( that is remarkable as trial started around this time in 2025 ) Love to be ahead of institutions. Watch your risk.
0 · Reply
OMM22
OMM22 Mar. 20 at 3:19 PM
$CTMX anyone in here or care to comment on the link
1 · Reply
OMM22
OMM22 Mar. 20 at 3:02 PM
$CTMX curious why is CTMX connected to silver whenever silver goes up this does 🤔🤔🤔🤔
1 · Reply
Latest News on CTMX
Why Is CytomX Therapeutics Stock Falling On Wednesday?

Mar 18, 2026, 1:06 PM EDT - 3 days ago

Why Is CytomX Therapeutics Stock Falling On Wednesday?


CytomX Therapeutics: Leaning Into The Hype, But What's Next?

Nov 18, 2025, 9:32 AM EST - 4 months ago

CytomX Therapeutics: Leaning Into The Hype, But What's Next?


Targeting Adhesion Molecules With ADC's: The Bet Of CytomX

Nov 11, 2025, 4:04 AM EST - 4 months ago

Targeting Adhesion Molecules With ADC's: The Bet Of CytomX


Top Biotech Stocks Riding The Rally

Nov 4, 2025, 3:15 PM EST - 4 months ago

Top Biotech Stocks Riding The Rally

GRAL GRFS INCY


CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study

Aug 13, 2025, 8:00 AM EDT - 7 months ago

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study


CytomX Therapeutics: Updated Outlook For Late 2025

Aug 8, 2025, 5:05 PM EDT - 8 months ago

CytomX Therapeutics: Updated Outlook For Late 2025


CytomX Therapeutics: Doubling Overnight On Phase 1 Data

May 13, 2025, 10:34 AM EDT - 11 months ago

CytomX Therapeutics: Doubling Overnight On Phase 1 Data


Bar_ryFlo
Bar_ryFlo Mar. 21 at 7:36 PM
$CTMX biotech under the radar and a tight coil here could expand fast with volume
1 · Reply
PleadNoContest
PleadNoContest Mar. 21 at 2:42 PM
$CTMX https://fintel.io/seps/us/ctmx This is one shtty earnings report. No FDA approved Varsetta until next year. Just a swarm of delusional pumpers.
1 · Reply
Terebc
Terebc Mar. 20 at 11:51 PM
$CTMX well too bad I didn’t wait, I bought 21,000 shares at 4.58 But I know this will go to 5.50 or more in a week or so
1 · Reply
PleadNoContest
PleadNoContest Mar. 20 at 9:35 PM
0 · Reply
Turdsniffer
Turdsniffer Mar. 20 at 7:44 PM
$CTMX pathetic
0 · Reply
LabPsycho
LabPsycho Mar. 20 at 6:05 PM
$CTMX @toandph Well, IMO, many of these biotechs are up 100-1200% in 11 months, and many have diluted huge along the way up,sucked many $ billions of dollars out of the now dried up biotech pool, so evern 60% retrace leaves many up substantially. I think the great unwinding started a few weeks ago. CTMX popped on early stage clinical results - the huge dilution with insider selling is rarely a good omen. I see this easily retracing below $4. Good luck.
2 · Reply
LabPsycho
LabPsycho Mar. 20 at 4:54 PM
$CTMX My calculations suggesting this is going below $4.25 soon
2 · Reply
biolover
biolover Mar. 20 at 4:32 PM
$MGNX With this fierce repetition from China on all classes of therapeutics. It is enticing to be FIC with descent time lead. That what I like about $MGNX adam9 ADC. Also GI expression ( in these cancers with limited ADC targets .. seen $CTMX trying to mask .. ) , no reported ILD and responses within one year of phase 1 start ( that is remarkable as trial started around this time in 2025 ) Love to be ahead of institutions. Watch your risk.
0 · Reply
OMM22
OMM22 Mar. 20 at 3:19 PM
$CTMX anyone in here or care to comment on the link
1 · Reply
OMM22
OMM22 Mar. 20 at 3:02 PM
$CTMX curious why is CTMX connected to silver whenever silver goes up this does 🤔🤔🤔🤔
1 · Reply
OMM22
OMM22 Mar. 20 at 2:22 PM
0 · Reply
Sagacious99
Sagacious99 Mar. 20 at 1:33 PM
$CTMX why did Sean hire Rachel Lester? She was given 675k options to do an offering!! Stupidity!!!
0 · Reply
Sagacious99
Sagacious99 Mar. 20 at 1:32 PM
$CTMX After this disaster of an offering, Don’t be surprised if an activist emerges!! Sean will be walking the plank!!
0 · Reply
Bionco
Bionco Mar. 20 at 12:52 AM
$CTMX The recent price action of CytomX feels strikingly similar to what I saw with Protagonist. When Protagonist dropped its Phase 2b data for Icotrokinra, the stock got crushed—down almost 30-50% in a single day. Many idiotic clowns came out from cave to bash the stock. Looking at the stock today, it is trading north of $100. Feels like CTMX could be setting up for a similar kind of comeback in the future.....
2 · Reply
avoid
avoid Mar. 19 at 11:05 PM
$CTMX On March 19, 2026, the offering closed and the Company completed the sale
0 · Reply
Totalreward
Totalreward Mar. 19 at 10:52 PM
$CTMX i am long here and more bullish
0 · Reply
dixiebull
dixiebull Mar. 19 at 9:10 PM
$CTMX looking for a pullback to 4 area for possible swing, but if 4.50 holds it can be a trade to 5+ $SWMR has 55 res now and 50 support. Over 55 to 58 and 60, or dip to 50 possible $AAOI ran to 105 test afterhours on a beautiful comeback, see if 100 holds, under that 98. If market is strong then AAOI can push 110 $BW will have 16 res so over that to 16.50 and 18 $VCX monster move for this SpaceX-holding fund, too new to really give direction yet but vwap is 80 and res is 100. It moves so much on so little volume so I will guide it as it goes.
1 · Reply
PleadNoContest
PleadNoContest Mar. 19 at 7:41 PM
$CTMX Am I serious? Fqqn yeah. Simple douche blocks me for asking and answers a question with a question. Scumbag pumper.
0 · Reply
toandph
toandph Mar. 19 at 7:26 PM
$CTMX do not short the stock more. the data is good, the orr even better than the current drug of MergeLab, make it the best in class currently. not sure why so bearish. one more phase 2 good result the company value will be 10b. it has risk? yes, but also a good chance to be 10x. its a good bet
2 · Reply
dybala
dybala Mar. 19 at 6:56 PM
$CTMX HC Wainwright & Co.'s Mitchell S. Kapoor maintained a "Buy" rating while raising the price target from $10.00 to $17.00, marking a 70% increase
0 · Reply
jamersonmoody
jamersonmoody Mar. 19 at 6:36 PM
$CTMX analysts pumping the stock 😂 they are always wrong
1 · Reply
PleadNoContest
PleadNoContest Mar. 19 at 6:16 PM
$CTMX Got a dead cat bounce here, for a bit today.
0 · Reply